CTAs keep buying Treasuries, gold longs face stop-loss risk: BofA
J. Birks Bovaird, a director at Energy Fuels (TSX:EFR) Inc. (NYSE:UUUU), recently sold 10,000 common shares of the company, according to a recent SEC filing. The shares were sold at a price of $5.44 each, amounting to a total transaction value of $54,400. The sale price sits between the stock’s 52-week range of $4.19 to $8.21, with analysts maintaining an optimistic outlook and a consensus high target of $11.00. According to InvestingPro analysis, while the company wasn’t profitable in the last twelve months, analysts expect it to turn profitable this year. Following this transaction, Bovaird holds 178,380 shares in the company. The sale was conducted on January 2, 2025, and was facilitated through a conversion from a Canadian sale price, taking into account the exchange rate at the time. For deeper insights into insider transactions and comprehensive analysis, InvestingPro subscribers can access detailed insider trading patterns and the company’s full financial health score, currently rated as FAIR.
In other recent news, Energy Fuels Inc. has been making significant strides in its growth strategy. The company has announced an agreement with the Republic of Madagascar, marking a crucial advancement in its Toliara Project. The Memorandum of Understanding (MOU) outlines terms for the titanium, zirconium, and rare earth elements project in southwestern Madagascar, following the lifting of a suspension imposed in 2019. Energy Fuels has committed to a 5% royalty on mining products and a contribution of $80 million towards development, community, and social projects post-Project Certification.
The company’s recent financial results reveal a net loss of $12.1 million in Q3 2024, largely due to transaction costs. However, Energy Fuels sold 50,000 pounds of uranium and maintained a substantial working capital of $183 million. Analyst firm H.C. Wainwright has maintained a Buy rating on Energy Fuels shares and increased the price target to $11.00 from $10.75, citing the company’s increased inventory and cash balance as key factors.
Energy Fuels is also considering expansion into the production of rare earth elements and has acquired Radtran, which is expected to begin production of medical isotopes for cancer therapies by early 2025. These recent developments are part of Energy Fuels’ broader commitment to responsible development and growth in critical mineral production.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.